← Open Payments lookup

SCOTT PINEGAR: Open Payments

NPI 1174009567 · ARVADA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,990 in 153 payments from 19 companies in 2025. Trend: 2023 $4,075 · 2024 $3,325 · 2025 $2,990

Food & beverage: $2,986Education: $4
CompanyPaymentsAmount
ABBVIE INC.47$621
Gilead Sciences, Inc.19$466
Takeda Pharmaceuticals U.S.A., Inc.12$346
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$224
Madrigal Pharmaceuticals8$199
Janssen Biotech, Inc.8$175
QOL Medical, LLC11$161
PFIZER INC.11$143
Regeneron Healthcare Solutions, Inc.6$126
GENZYME CORPORATION4$96

Products named: RINVOQ, DUPIXENT, XIFAXAN, REZDIFFRA, ENTYVIO, TREMFYA, EOHILIA, Sucraid.

Industry payments across CO — which companies pay providers there.